Comment on 23andMe wants to go private. It’s the latest in a line of failed SPACs

23andMe wants to go private. It’s the latest in a line of failed SPACs

Like BuzzFeed and Virgin Galactic, the DNA-testing powerhouse is another company with a buzzy SPAC debut whose stock fell to under $1 in recent weeks. Like a number of companies that went public during the pandemic, 23andMe has for months been trying to manage a terrible case of SPAC-itis, an inflammation that causes plunging stock values due to the business being, as one analyst put it, not “ready for prime time.”

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News